Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation Journal Article


Authors: Andersen, B. L.; DeRubeis, R. J.; Berman, B. S.; Gruman, J.; Champion, V. L.; Massie, M. J.; Holland, J. C.; Partridge, A. H.; Bak, K.; Somerfield, M. R.; Rowland, J. H.
Article Title: Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation
Abstract: Purpose: A Pan-Canadian Practice Guideline on Screening, Assessment, and Care of Psychosocial Distress (Depression, Anxiety) in Adults With Cancer was identified for adaptation. Methods: American Society of Clinical Oncology (ASCO) has a policy and set of procedures for adapting clinical practice guidelines developed by other organizations. The guideline was reviewed for developmental rigor and content applicability. Results: On the basis of content review of the pan-Canadian guideline, the ASCO panel agreed that, in general, the recommendations were clear, thorough, based on the most relevant scientific evidence, and presented options that will be acceptable to patients. However, for some topics addressed in the pan-Canadian guideline, the ASCO panel formulated a set of adapted recommendations based on local context and practice beliefs of the ad hoc panel members. It is recommended that all patients with cancer be evaluated for symptoms of depression and anxiety at periodic times across the trajectory of care. Assessment should be performed using validated, published measures and procedures. Depending on levels of symptoms and supplementary information, differing treatment pathways are recommended. Failure to identify and treat anxiety and depression increases the risk for poor quality of life and potential disease-related morbidity and mortality. This guideline adaptation is part of a larger survivorship guideline series. Conclusion: Although clinicians may not be able to prevent some of the chronic or late medical effects of cancer, they have a vital role in mitigating the negative emotional and behavioral sequelae. Recognizing and treating effectively those who manifest symptoms of anxiety or depression will reduce the human cost of cancer. (C) 2014 by American Society of Clinical Oncology
Keywords: questionnaire; cognitive therapy; major depression; breast-cancer; quality-of-life; metaanalysis; psychometric properties; rating-scale; survivorship care; patient health questionnaire; state worry
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Start Page: 1605
End Page: 1619
Language: English
ACCESSION: WOS:000336733000015
DOI: 10.1200/jco.2013.52.4611
PROVIDER: wos
PUBMED: 24733793
PMCID: PMC4090422
Notes: Article -- Source: Wos
Altmetric Score
MSK Authors
  1. Jimmie C B Holland
    228 Holland
  2. Mary Jane Massie
    49 Massie